News
You are here: Home » News

News and Events

2025
DATE
06 - 04
Global API Market Trends: Innovation and Supply Chain Resilience in Focus
The global Active Pharmaceutical Ingredient (API) market continues to experience robust growth, driven by innovation in drug development, increasing demand for generic medicines, and a renewed emphasis on supply chain resilience. According to recent industry data, the API sector is expected to surpa
Read More
2024
DATE
11 - 25
Changzhou Ruiming Pharmaceutical: Driven by scientific and technological innovation, it helps a new chapter in diabetes treatment
Under the severe challenge of diabetes as a global health problem, Changzhou Ruiming Pharmaceutical Co., LTD. (hereinafter referred to as "Ruiming Pharmaceutical") is gradually becoming a new force in the field of diabetes treatment with its profound accumulation and unremitting innovation in the fi
Read More
2024
DATE
11 - 25
Intensified Air Pollution Control in Autumn And Winter: How Should API Equipment Enterprises Respond?
As most regions enter the autumn-winter mode, environmental issues such as smog are becoming focal points for public concern. Experts suggest that with the introduction of action plans to combat environmental pollution, many small and medium-sized API (Active Pharmaceutical Ingredient) enterprises u
Read More
2023
DATE
02 - 02
Sensitive and rapid detection of TERT promoter and IDH mutations in diffuse gliomas
Liquid biopsies, based on cell free DNA (cfDNA) and proteins, have shown the potential to detect early stage cancers of diverse tissue types. However, most of these studies were retrospective, using individuals previously diagnosed with cancer as cases and healthy individuals as controls. Here, we d
Read More
2023
DATE
02 - 02
Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
Liquid biopsies, based on cell free DNA (cfDNA) and proteins, have shown the potential to detect early stage cancers of diverse tissue types. However, most of these studies were retrospective, using individuals previously diagnosed with cancer as cases and healthy individuals as controls. Here, we d
Read More
2023
DATE
02 - 02
Biological Role and Therapeutic Potential of IDH Mutations in Cancer
Liquid biopsies, based on cell free DNA (cfDNA) and proteins, have shown the potential to detect early stage cancers of diverse tissue types. However, most of these studies were retrospective, using individuals previously diagnosed with cancer as cases and healthy individuals as controls. Here, we d
Read More
Specializing in the development, production and sales of pharmaceutical raw materials and their intermediates.
  0519-85095533
+86 18261172629
 +86 18118380910             
  No. 1558 Longjiang Bei Road Chunjiang Town Xinbei District, Changzhou City, Jiangsu Province,China

QUICK LINKS

Solution

PRODUCT CATEGORY

Intermediates of Amlodipine Besylate
Copyright © 2024 Changzhou Ruiming Pharmaceutical Co., Ltd. All Rights Reserved. Sitemap
Contact Us